- Home
- CAAS vs AVTX Comparison
CAAS vs AVTX Comparison
Compare CAAS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAS
- AVTX
- Stock Information
- Founded
- CAAS N/A
- AVTX 2011
- Country
- CAAS China
- AVTX United States
- Employees
- CAAS N/A
- AVTX N/A
- Industry
- CAAS Auto Parts:O.E.M.
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- CAAS Consumer Discretionary
- AVTX Health Care
- Exchange
- CAAS Nasdaq
- AVTX Nasdaq
- Market Cap
- CAAS 111.1M
- AVTX 90.9M
- IPO Year
- CAAS N/A
- AVTX 2015
- Fundamental
- Price
- CAAS $3.90
- AVTX $9.38
- Analyst Decision
- CAAS
- AVTX Buy
- Analyst Count
- CAAS 0
- AVTX 3
- Target Price
- CAAS N/A
- AVTX $29.50
- AVG Volume (30 Days)
- CAAS 35.5K
- AVTX 90.5K
- Earning Date
- CAAS 11-13-2024
- AVTX 11-07-2024
- Dividend Yield
- CAAS N/A
- AVTX N/A
- EPS Growth
- CAAS 2.02
- AVTX N/A
- EPS
- CAAS 1.05
- AVTX N/A
- Revenue
- CAAS $621,377,000.00
- AVTX $820,000.00
- Revenue This Year
- CAAS $4.97
- AVTX N/A
- Revenue Next Year
- CAAS N/A
- AVTX N/A
- P/E Ratio
- CAAS $3.99
- AVTX N/A
- Revenue Growth
- CAAS 13.81
- AVTX N/A
- 52 Week Low
- CAAS $3.05
- AVTX $3.95
- 52 Week High
- CAAS $4.97
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- CAAS 31.61
- AVTX 38.65
- Support Level
- CAAS $4.32
- AVTX $8.77
- Resistance Level
- CAAS $4.52
- AVTX $9.82
- Average True Range (ATR)
- CAAS 0.19
- AVTX 0.79
- MACD
- CAAS -0.04
- AVTX -0.03
- Stochastic Oscillator
- CAAS 2.86
- AVTX 18.89
About CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).